92 related articles for article (PubMed ID: 21259412)
1. SSTR1- and SSTR3-selective somatostatin analogues.
Ramón R; Martín-Gago P; Verdaguer X; Macias MJ; Martin-Malpartida P; Fernández-Carneado J; Gomez-Caminals M; Ponsati B; López-Ruiz P; Cortés MA; Colás B; Riera A
Chembiochem; 2011 Mar; 12(4):625-32. PubMed ID: 21259412
[TBL] [Abstract][Full Text] [Related]
2. Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides.
Raynor K; Murphy WA; Coy DH; Taylor JE; Moreau JP; Yasuda K; Bell GI; Reisine T
Mol Pharmacol; 1993 Jun; 43(6):838-44. PubMed ID: 8100350
[TBL] [Abstract][Full Text] [Related]
3. Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
Erchegyi J; Penke B; Simon L; Michaelson S; Wenger S; Waser B; Cescato R; Schaer JC; Reubi JC; Rivier J
J Med Chem; 2003 Dec; 46(26):5587-96. PubMed ID: 14667213
[TBL] [Abstract][Full Text] [Related]
4. Conformational analysis of a potent SSTR3-selective somatostatin analogue by NMR in water solution.
Gairí M; Saiz P; Madurga S; Roig X; Erchegyi J; Koerber SC; Reubi JC; Rivier JE; Giralt E
J Pept Sci; 2006 Feb; 12(2):82-91. PubMed ID: 16365912
[TBL] [Abstract][Full Text] [Related]
5. Characterization of cloned somatostatin receptors SSTR4 and SSTR5.
Raynor K; O'Carroll AM; Kong H; Yasuda K; Mahan LC; Bell GI; Reisine T
Mol Pharmacol; 1993 Aug; 44(2):385-92. PubMed ID: 8102785
[TBL] [Abstract][Full Text] [Related]
6. Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
Erchegyi J; Waser B; Schaer JC; Cescato R; Brazeau JF; Rivier J; Reubi JC
J Med Chem; 2003 Dec; 46(26):5597-605. PubMed ID: 14667214
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for the binding specificity of a SSTR1-selective analog of somatostatin.
Chen L; Hoeger C; Rivier J; Fitzpatrick VD; Vandlen RL; Tashjian AH
Biochem Biophys Res Commun; 1999 May; 258(3):689-94. PubMed ID: 10329447
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin and its receptor family.
Patel YC
Front Neuroendocrinol; 1999 Jul; 20(3):157-98. PubMed ID: 10433861
[TBL] [Abstract][Full Text] [Related]
9. Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan.
Rivier J; Erchegyi J; Hoeger C; Miller C; Low W; Wenger S; Waser B; Schaer JC; Reubi JC
J Med Chem; 2003 Dec; 46(26):5579-86. PubMed ID: 14667212
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin receptor 1 selective analogues: 4. Three-dimensional consensus structure by NMR.
Grace CR; Durrer L; Koerber SC; Erchegyi J; Reubi JC; Rivier JE; Riek R
J Med Chem; 2005 Jan; 48(2):523-33. PubMed ID: 15658866
[TBL] [Abstract][Full Text] [Related]
11. Novel sst(4)-selective somatostatin (SRIF) agonists. 4. Three-dimensional consensus structure by NMR.
Grace CR; Koerber SC; Erchegyi J; Reubi JC; Rivier J; Riek R
J Med Chem; 2003 Dec; 46(26):5606-18. PubMed ID: 14667215
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological properties of two cloned somatostatin receptors.
Rens-Domiano S; Law SF; Yamada Y; Seino S; Bell GI; Reisine T
Mol Pharmacol; 1992 Jul; 42(1):28-34. PubMed ID: 1353250
[TBL] [Abstract][Full Text] [Related]
13. Peptide aromatic interactions modulated by fluorinated residues: Synthesis, structure and biological activity of Somatostatin analogs containing 3-(3',5'difluorophenyl)-alanine.
Martín-Gago P; Rol Á; Todorovski T; Aragón E; Martin-Malpartida P; Verdaguer X; Vallès Miret M; Fernández-Carneado J; Ponsati B; Macias MJ; Riera A
Sci Rep; 2016 Jun; 6():27285. PubMed ID: 27271737
[TBL] [Abstract][Full Text] [Related]
14. Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization.
Reubi JC; Schaer JC; Waser B; Mengod G
Cancer Res; 1994 Jul; 54(13):3455-9. PubMed ID: 8012966
[TBL] [Abstract][Full Text] [Related]
15. Development of a selective agonist at the somatostatin receptor subtype sstr1.
Liapakis G; Hoeger C; Rivier J; Reisine T
J Pharmacol Exp Ther; 1996 Mar; 276(3):1089-94. PubMed ID: 8786539
[TBL] [Abstract][Full Text] [Related]
16. Peptide-chelating agent conjugate for selective targeting of somatostatin receptor type 1: synthesis and characterization.
Mansi R; Tesauro D; De Capua A; Fattorusso R; Caracò C; Aloj L; Benedetti E; Morelli G
Biopolymers; 2004; 76(6):527-34. PubMed ID: 15526334
[TBL] [Abstract][Full Text] [Related]
17. Replacement of Phe6, Phe7, and Phe11 of D-Trp8-somatostatin-14 with L-pyrazinylalanine. Predicted and observed effects on binding affinities at hSST2 and hSST4. An unexpected effect of the chirality of Trp8 on NMR spectra in methanol.
Neelamkavil S; Arison B; Birzin E; Feng JJ; Chen KH; Lin A; Cheng FC; Taylor L; Thornton ER; Smith AB; Hirschmann R
J Med Chem; 2005 Jun; 48(12):4025-30. PubMed ID: 15943475
[TBL] [Abstract][Full Text] [Related]
18. A single amino acid substitution in somatostatin receptor subtype 5 increases affinity for somatostatin-14.
Ozenberger BA; Hadcock JR
Mol Pharmacol; 1995 Jan; 47(1):82-7. PubMed ID: 7838136
[TBL] [Abstract][Full Text] [Related]
19. Mutation of an aspartate at residue 89 in somatostatin receptor subtype 2 prevents Na+ regulation of agonist binding but does not alter receptor-G protein association.
Kong H; Raynor K; Yasuda K; Bell GI; Reisine T
Mol Pharmacol; 1993 Aug; 44(2):380-4. PubMed ID: 8102784
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin receptor subtypes 2 and 5 mediate inhibition of egg yolk-induced gall bladder emptying in mice.
Kaczmarek P; Singh V; Cashen DE; Yang L; Berk S; Pasternak A; Xiong Y; Shen DM; Hutchins SM; Chapman K; Wiedenmann B; Schaeffer JM; Strowski MZ
Neurogastroenterol Motil; 2010 Feb; 22(2):204-9, e66. PubMed ID: 19754922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
